ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE)
Clinical trials for ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE) explained in plain language.
Never miss a new study
Get alerted when new ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE) trials appear
Sign up with your email to follow new studies for ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cholesterol pill could be new hope for slowing inherited kidney disease
Disease control Not yet recruitingThis study is testing if bempedoic acid, a drug already approved for high cholesterol, can safely slow the progression of autosomal dominant polycystic kidney disease (ADPKD). About 120 adults with ADPKD will take either the drug or a placebo pill for two years to see if it reduc…
Matched conditions: ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE)
Phase: PHASE2 • Sponsor: Kenneth Hallows • Aim: Disease control
Last updated Apr 02, 2026 04:26 UTC
-
First human test: does new kidney drug mess with your heartbeat?
Knowledge-focused Not yet recruitingThis is an early safety study to see if a single dose of an experimental drug called JMKX003142 affects the heart's electrical rhythm in healthy people. The drug is being developed for a genetic kidney disease called ADPKD. Researchers will compare the drug's effects to a placebo…
Matched conditions: ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE)
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Scientists track experimental drug's journey through the body
Knowledge-focused Not yet recruitingThis early study aims to understand how the body absorbs, processes, and eliminates an experimental drug called JMKX003142. It will involve 8 healthy male volunteers. Researchers will track how much of the drug gets into the bloodstream and how it leaves the body to help design f…
Matched conditions: ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE)
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC